RECURSION PHARMACEUTICALS-A (RXRX) Institutional Ownership Changes & 13F Activity

RECURSION PHARMACEUTICALS-A (RXRX) institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC 13F filings (Q1 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions among tracked filers. Notable filers include ARK Invest, Renaissance Technologies LLC, and Sequoia Financial Advisors.

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q1 2026ARK InvestBuy2,895,91340,212,769$123,453,202
Q1 2026Renaissance Technologies LLCBuy2,050,6052,400,605$7,369,857
Q1 2026Sequoia Financial AdvisorsBuy5,15615,162$46,548
Q4 2025ARK InvestBuy3,771,35737,316,856$152,625,940
Q4 2025Sequoia Financial AdvisorsSell-2,39310,006$40,925
Q3 2025ARK InvestBuy556,86833,545,499$163,702,036
Q2 2025ARK InvestSell-1,826,87132,988,631$166,922,471
Q2 2025Sequoia Financial AdvisorsSell-20612,399$62,739
Q1 2025ARK InvestBuy2,469,10434,815,502$184,174,004
Q1 2025Sequoia Financial AdvisorsBuy12,60512,605$66,681
Q4 2024ARK InvestSell-422,78832,346,398$218,661,650
Q3 2024ARK InvestBuy4,626,26832,769,186$215,948,936
Q2 2024ARK InvestBuy3,555,35728,142,918$211,071,885
Q1 2024ARK InvestBuy3,933,27424,587,561$245,137,979
Q4 2023ARK InvestBuy13,777,68920,654,287$203,651,265
Q3 2023ARK InvestBuy2,138,0816,876,598$52,605,973
Q2 2023ARK InvestBuy1,161,6554,738,517$35,396,723
Q2 2023Renaissance Technologies LLCSell-65,561350,000$2,615
Q1 2023ARK InvestBuy477,3723,576,862$23,857,670
Q1 2023Renaissance Technologies LLCBuy221,661415,561$2,772
Q4 2022ARK InvestSell-260,3213,099,490$23,897,068
Q4 2022Renaissance Technologies LLCBuy178,700193,900$1,495
Q3 2022ARK InvestBuy627,7243,359,811$35,748
Q3 2022Renaissance Technologies LLCSell-246,40015,200$162
Q2 2022ARK InvestSell-95,0762,732,087$16,720
Q2 2022Renaissance Technologies LLCBuy83,200261,600$2,129
Q1 2022ARK InvestBuy595,1502,827,163$20,242
Q1 2022Renaissance Technologies LLCBuy178,400178,400$1,277
Q4 2021ARK InvestSell-361,8232,232,013$38,234
Q3 2021ARK InvestBuy215,1612,593,836$59,684

Frequently asked questions about RXRX activity

  • Which institutional owners are buying RXRX?

    Institutional owners buying RXRX include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in RXRX activity?

    "Buy" means an investor increased their reported position in RXRX compared to the prior reporting period. This reflects growing exposure to RECURSION PHARMACEUTICALS-A (RXRX) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in RXRX increasing?

    Institutional interest in RXRX can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.

Related RXRX insights